U.K. Adverse Events System Will Allow Patients To Submit Reports, Review Data
This article was originally published in The Pink Sheet Daily
Executive Summary
The Medicines & Healthcare Products Regulatory Agency will have a final system for direct patient reporting of adverse events by 2006, the agency says. MHRA seems to acknowledge the careful balance required to post adverse event data without deterring appropriate drug use.
You may also be interested in...
FDA Begins Publishing Raw Adverse Event Data From AERS
The agency's website includes quarterly data from its Adverse Events Reporting System. FDA's goal is to publish the AERS data within two weeks after the quarter's end.
FDA Begins Publishing Raw Adverse Event Data From AERS
The agency's website includes quarterly data from its Adverse Events Reporting System. FDA's goal is to publish the AERS data within two weeks after the quarter's end.
FDA Drug Safety Initiative Will Include New Website On Rx Risks
The site is intended as an avenue for the agency to disclose safety issues that have not yet been definitively reviewed, and to emphasize the risks with all prescription drugs. The website proposal is understood to be in the internal agency review phase.